CAGGIANO, Anthony,PARRY, Tom,GANGULY, Anindita,IACI, Jennifer
申请号：
DK09813336
公开号：
DK2320933T3
申请日:
2009.07.17
申请国别(地区):
DK
年份:
2018
代理人:
摘要：
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
